The third world countries are sometimes in the most need of the new medicines that are being made by the generic name and this could be one way of getting them what they need.
To make a solution the World Trade Organization or WTO made a legislation in 2003 that could allow the third world countries to let them know which medications require and allow companies licenses to produce generic versions of patented drugs to fill this demand up.
Some may fear that the drugs be re imported and also back to the west where the seller would get a great profit rather than going to benefit those that are in need of strict regulation that the drug can be produced and imported for humanitarian reasons.
One other problem is to ensure that the prices remain low so that the developing countries can afford them. This will require a market that is big enough to attract large amounts of competition that will help to lower the prices.
There are some claims that the large Pharmaceutical companies are stopping efforts by countries like India to produce cheaper generic versions of their own drugs. Drugs that are made cheaper in these countries are usually important to the west rather than going to those that are in need of them.
One in four aids patients have access to the HIV drugs that they need to keep alive. There is one in five that have access to the basic prevention services. There are currently around 33,000,000 people that are living with HIV and AIDS today.
To make a solution the World Trade Organization or WTO made a legislation in 2003 that could allow the third world countries to let them know which medications require and allow companies licenses to produce generic versions of patented drugs to fill this demand up.
Some may fear that the drugs be re imported and also back to the west where the seller would get a great profit rather than going to benefit those that are in need of strict regulation that the drug can be produced and imported for humanitarian reasons.
One other problem is to ensure that the prices remain low so that the developing countries can afford them. This will require a market that is big enough to attract large amounts of competition that will help to lower the prices.
There are some claims that the large Pharmaceutical companies are stopping efforts by countries like India to produce cheaper generic versions of their own drugs. Drugs that are made cheaper in these countries are usually important to the west rather than going to those that are in need of them.
One in four aids patients have access to the HIV drugs that they need to keep alive. There is one in five that have access to the basic prevention services. There are currently around 33,000,000 people that are living with HIV and AIDS today.
Posts
No comments:
Post a Comment